Alzheimer’s disease: Imaging modalities to support diagnosis
This module presents a summary of the role of neuroimaging in clinical practice and its real-world application to support diagnosis of Alzheimer’s disease.
The module reviews the use of structural imaging in the diagnostic journey and the assessment of atrophy and vascular changes with MRI (magnetic resonance imaging). It also describes the use of neuroimaging markers such as Amyloid PET (positron emission tomography) to support diagnosis. An introduction to amyloid PET tracers is provided as well as recommendations and guidelines on its clinical utility. To conclude, other imaging modalities are described.
The content provided is only for your own individual educational and non-commercial use. Any additional use, including use with other individuals or for any commercial use, is strictly prohibited without obtaining express permission from the copyright owner.
This video will review imaging modalities in Alzheimer’s disease including MRI, high-resolution CT and Amyloid PET, as well as clinical utility of amyloid PET tracers.